OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.

The structural characteristics indicated in this column were the ones of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.

For the implementation of the common principles of Annex VI to Regulation (EU) No 528/2012, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/comm/environment/biocides/index.htm

Common NameIUPAC NameIdentification NumbersMinimum degree of purity of the active substancef1 Reference structural characteristicsf2 Date of approvalExpiry date of approvalProduct typeSpecific conditionsf3
Synthetic amorphous silicon dioxide (nano)

IUPAC Name:

Silicon dioxide

EC No: 231-545-4

CAS No: 112926-00-8

This approval covers synthetic amorphous silicon dioxide as a nanomaterial in the form of stable aggregated particles of particle size > 1 μm, with primary particles of nanosize.

800 g/kg
  • Size of stable aggregated particles > 1 μm

  • Primary particle size < 25 nm

  • Volume specific surface area > 600 m2/cm3

1 November 201531 October 202518The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.

Annotations

Footnotes

f1

The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.

f2

The structural characteristics indicated in this column were the ones of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.

f3

For the implementation of the common principles of Annex VI to Regulation (EU) No 528/2012, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/comm/environment/biocides/index.htm